Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group

2008150 citationsJournal Articlehybrid Open Access

Authors

Andrew L. Gilman · Levine Children's Hospital

M. Fevzi Özkaynak · New York Medical College

Katherine K. Matthay · Children's Hospital of Wisconsin

Mark Krailo · Children's Hospital of Wisconsin

Alice L. Yu · Levine Children's Hospital

Jacek Gan · Children's Hospital of Wisconsin

Adam Sternberg

Abstract

ch14.18 in combination with IL-2 was tolerable in the early post-HDC/SCR period. cis-RA can be administered safely between courses of ch14.18 and cytokines.

Topics & Keywords

Neuroblastoma Research and Treatments Cancer therapeutics and mechanisms Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 27, Issue 1, pp. 85-91

DOI: 10.1200/jco.2006.10.3564

Field-Weighted Citation Impact: 6.66